Neuroendocrinology
Reproductive Neuroendocrinology
Neuroendocrinology of Aging in Humans: Attenuated Sensitivity to Sex Steroid Feedback in Elderly Postmenopausal WomenRossmanith W.G.a · Reichelt C.a · Scherbaum W.A.bDepartments of aObstetrics-Gynecology and bInternal Medicine, University of Ulm, FRG
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: February 23, 1993
Accepted: September 29, 1993
Published online: April 08, 2008
Issue release date: 1994
Number of Print Pages: 8
Number of Figures: 0
Number of Tables: 0
ISSN: 0028-3835 (Print)
eISSN: 1423-0194 (Online)
For additional information: https://www.karger.com/NEN
Abstract
Studies in experimental animals have shown that the sensitivity of the hypothalamic-pituitary system to ovarian sex steroid feedback declines while aging progresses. Since similar observations are lacking in humans, we studied the gonadotropin secretion of postmenopausal women (PMW) of different ages before and following a 7-day course of oral clomiphene citrate (CC, 100 mg daily). For serial determinations of serum luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels, blood was sampled frequently from 5 younger PMW (mean age 55.2 years) and 6 older PMW (mean age 80.3 years) for 10 h. Eight hours after initiation of blood sampling, gonadotropin-releasing hormone (GnRH, 25 µg) was administered. Compared to untreated conditions, CC administration did not significantly change the serum concentrations of the estrogens (estrone, estradiol) and androgens (testosterone; androstenedione, dehydroepiandrosterone sulfate). However, CC increased the sex hormone-binding globulin levels in both younger and older PMW, suggestive of the estrogenic effects of this compound. In the unstimulated secretory profiles of younger PMW, mean LH levels decreased (p < 0.05) in response to CC, presumably a consequence of decreased (p < 0.05) pulse frequencies, but not pulse amplitudes. Likewise, by virtue of decreased (p < 0.05) FSH pulse amplitudes, FSH levels declined (p < 0.05) in younger PMW. In contrast, both the LH and FSH levels and their pulsatility remained virtually unaltered following CC administrations to older PMW. The GnRH-mediated gonadotropin release was uneffected by CC administrations in either group of PMW. Thus, the use of an anti-estrogen as a pharmacological probe revealed that the sensitivity of the hypothalamic-pituitary axis to negative feedback is attenuated with advanced age in PMW. Since the gonadotropin responsiveness to GnRH stimulations remained unaltered during CC administrations, we infer that the age-related attenuation of feedback sensitivity rather relates to a hypothalamic decline than to a pituitary hypofunction.
© 1994 S. Karger AG, Basel
Related Articles:
Article / Publication Details
Received: February 23, 1993
Accepted: September 29, 1993
Published online: April 08, 2008
Issue release date: 1994
Number of Print Pages: 8
Number of Figures: 0
Number of Tables: 0
ISSN: 0028-3835 (Print)
eISSN: 1423-0194 (Online)
For additional information: https://www.karger.com/NEN
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
